Article
Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance.
Biochemical pharmacology - 15 May 1998
Fu L, Cheng Y C
Abstract excerpt
L(-)SddC (3TC) has been shown to be the most promising nucleoside analogue used for the treatment of hepatitis B virus (HBV) infection. Unfortunately, it has been reported that about 12% of HBV-infected patients experience a recurrence of HBV after a period of treatment with 3TC. Point mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
